In vivo single-cell CRISPR screening for microproteins identifies a critical ribosomal component
The study used an in vivo single-cell CRISPR screening approach in mouse epidermis to investigate tissue-wide functions of microproteins at single-cell transcriptomic resolution, assessing both global and cell-type-specific roles during epidermal development and homeostasis. From selected candidates, the authors identified a microprotein on Gm10076 that is identical to the ribosomal intersubunit bridge protein RPL41, where perturbation strongly impaired proliferation and protein synthesis. Using ribosome profiling and RNA sequencing, they showed Gm10076 perturbation profoundly reshaped the translational landscape, and they report that RPL41 is essential for cellular proliferation, contrary to prior classification as nonessential. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
1,395 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00